ethyl 2-(4-cyclohexyl-5-sulfanylidene-4,5-dihydro-1H-1,2,4-triazol-3-yl)acetate, 97%, 100mg

2-C-Methyl-D-ribonoic acid-1,4-Lactone, 95.0%, 25g

2-bromo-5-methyl-4-nitrophenol, 95%, 250mg

Tetrabutylammonium fluoride, 1 mol/l in THF, stab., 250 ml, glass packaging

Ferrocenecarboxaldehyde, 95.0%, 1g

Iron(II) sulphate heptahydrate, 5 kg

(3R,4R)-tert-Butyl 3-((tert-butoxycarbonyl)amino)-4-hydroxypyrrolidine-1-carboxylate, 97.0%, 1g

p-NN-Bis(2-chloroethyl)aminobenzaldehyde, 99%, 1g

Potassium 2,2-dimethyl-1,3-dioxolane-4-carboxylate, 95.0%, 1g

(R)-1-(6-Methoxypyridin-2-yl)ethanamine, 98%, 250mg

2,4,6-Trifluoro-1-(methoxymethoxy)benzene, 98%, 1g

4,5-Dihydro-2-phenyloxazole>98.0%(GC)(T)5g

6-BROMO-7-CHLORO-3H-IMIDAZO[4,5-B]PYRIDINE, 95.0%, 1g